|
Volumn 11, Issue 3, 2008, Pages 525-539
|
Cost effectiveness of asthma treatment with a breath-actuated inhaler: How has the story changed?
|
Author keywords
Asthma; Breath actuated; Cost effectiveness; Easi Breathe *; Economic evaluation; Inhaler
|
Indexed keywords
AMOXICILLIN;
ANTIBIOTIC AGENT;
BECLOMETASONE;
BECLOMETASONE DIPROPIONATE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
PREDNISOLONE;
SHORT ACTING DRUG;
STEROID;
ARTICLE;
ASTHMA;
BREATH ACTUATED INHALER;
CLINICAL EFFECTIVENESS;
CONTROLLED STUDY;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DATA BASE;
DRUG COST;
DRUG DOSAGE FORM COMPARISON;
ECONOMIC EVALUATION;
HEALTH CARE UTILIZATION;
HUMAN;
INHALER;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
METERED DOSE INHALER;
OBSERVATIONAL STUDY;
PRIMARY MEDICAL CARE;
TREATMENT DURATION;
TREATMENT OUTCOME;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
BECLOMETHASONE;
COHORT STUDIES;
COST-BENEFIT ANALYSIS;
FEES, PHARMACEUTICAL;
HEALTH EXPENDITURES;
HUMANS;
NEBULIZERS AND VAPORIZERS;
RETROSPECTIVE STUDIES;
|
EID: 55049104532
PISSN: 13696998
EISSN: None
Source Type: Journal
DOI: 10.3111/13696990802340856 Document Type: Article |
Times cited : (2)
|
References (9)
|